Vasopressin V2 Receptor Antagonist class drugs

2 results
Otsuka America Pharmaceutical, Inc.
Usage: JYNARQUE is indicated for adults at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD) to help slow the decline of kidney function.
Otsuka America Pharmaceutical, Inc.
Usage: SAMSCA® is indicated for treating clinically significant hypervolemic and euvolemic hyponatremia (serum sodium <125 mEq/L) in patients, including those with heart failure and SIADH. It is not meant for urgent serum sodium increases to prevent neurological symptoms, nor is its symptomatic benefit established.